Table 1 Study information for military recruits
From: Epidemiology of musculoskeletal injury in military recruits: a systematic review and meta-analysis
Study | Country | Military service | Study design | Sampling timeframe | Duration of recruit training (weeks) | Injury case definition | Injury reporting (prospective/ retrospective) |
|---|---|---|---|---|---|---|---|
Billings 2004 [40] | United States of America | Airforce | Cohort study | 2002 | 6 | Medical attention | Prospective |
Blacker 2008 [11] | United Kingdom | Army | Cohort study | 2003–2005 | 12 | Medical attention | Retrospective |
Booth 2006 [3] | Australia | Army | Cohort study | 2003 | 6 | Medical attention | Prospective |
Brooks 2019 [41] | United States of America | Army | Cohort study | 2007 | 9 | Medical attention | Retrospective |
Brushøj 2008 [42] | Denmark | Army | Randomised intervention trial | 2004–2005 | 12 | Medical attention | Prospective |
Burley 2020 [43] | Australia | Army | Randomised intervention trial | Not reported | 12 | Medical attention | Prospective |
Chassé 2020 [16] | Canada | Not reported | Cohort study | 2016–2017 | 12 | Medical attention | Prospective |
United States of America | Army | Cohort study | 2005–2006 | 10 | Medical attention | Retrospective | |
Cowan 2012 [44] | United States of America | Army | Cohort study | 2005–2006 | Not reported | Medical attention | Prospective |
Dawson 2015 [45] | Australia | Army | Cohort study | 2013 | 12 | Medical attention | Prospective |
Din 2016 [46] | Malaysia | Army | Cohort study | 2013–2014 | 26 | Medical attention | Prospective |
Esterman 2005 [17] | Australia | Airforce | Randomised intervention trial | Not reported | 10 | Time-loss | Prospective |
Everard 2018 [47] | Ireland | Army | Cohort study | Not reported | 16 | Time-loss | Prospective |
Fallowfield 2020 [12] | United Kingdom | Airforce | Cohort study | 2008 | 9 | Time-loss | Prospective |
Goodall 2013 [48] | Australia | Army | Randomised intervention trial | 2007 | 12 | Medical attention | Prospective |
Hall 2017 [13] | United Kingdom | Army | Cohort study | 2009–2011 | 14 | Medical attention | Prospective |
Hauschild 2018 [8] | United States of America | Army | Cohort study | 2016 | 10 | Medical attention | Prospective |
Havenetidis 2011 [49] | Greece | Army | Cohort study | Not reported | 7 | Medical attention | Prospective |
Havenetidis 2017 [50] | Greece | Army | Cohort study | Not reported | 7 | Medical attention | Prospective |
Heagerty 2018 [18] | United Kingdom | Army | Cohort study | 2012–2016 | 28 | Medical attention | Prospective |
Heller 2020 [4] | United Kingdom | Army | Cohort study | 2016–2017 | 14 | Time-loss | Prospective |
Hofstetter 2012 [51] | Sweden | Army | Randomised intervention trial | 2009–2010 | 7 | Medical attention | Prospective |
Jones 2017 [19] | United States of America | Army | Cohort study | 2009 – 2012 | 10 | Medical attention | Prospective |
Kerr 2004 [52] | Ireland | Army | Cohort study | 2000 – 2001 | 16 | Medical attention | Prospective |
Knapik 2006 [54] | United States of America | Army | Non-randomised intervention trial | 2003 | 9 | Medical attention | Prospective |
Knapik 2010a [53] | United States of America | Airforce | Randomised intervention trial | 2007 | 6 | Medical attention | Prospective |
Knapik 2010b [55] | United States of America | Marines | Randomised intervention trial | Not reported | 12 | Medical attention | Prospective |
Mohammadi 2013 [56] | Iran | Army | Cohort Study | Not reported | 8 | Medical attention | Prospective |
Müller-Schilling 2019 [5] | Germany | Army | Cohort Study | 2012 – 2014 | Not reported | Time-loss | Prospective |
Munnoch 2007 [57] | United Kingdom | Marines | Cohort Study | 2001 – 2002 | 32 | Medical attention | Prospective |
Nye 2016 [22] | United States of America | Airforce | Cohort study | 2012–2014 | 8.5 | Medical attention | Prospective |
O’Connor 2011 [20] | United States of America | Marines | Cohort study | 2009 | 16 | Medical attention | Prospective |
Orr 2020 [14] | Australia | Army | Cohort study | 2006–2011 | 12 | Medical attention | Prospective |
Australia | Army (Reserves) | Cohort study | 2006–2011 | 4 | Medical attention | Prospective | |
Roos 2015 [6] | Switzerland | Army | Non-randomised intervention trial | Not reported | 21 | Medical attention | Prospective |
Schram 2019i [9] | Australia | Army | Cohort study | 2012–2014 | 12 | Medical attention | Retrospective |
Australia | Army (Reserves) | Cohort study | 2012–2014 | 4 | Medical attention | Retrospective | |
United Kingdom | Army | Cohort study | Not reported | 26 | Medical attention | Prospective | |
United Kingdom | Army | Cohort study | 2006 – 2008 | 26 | Medical attention | Prospective | |
Trone 2014 [58] | United States of America | Marines | Cohort study | 2007 | 12 | Medical attention | Prospective |
Withnall 2006 [59] | United Kingdom | Airforce | Randomised intervention trial | 2003 – 2004 | 9 | Time-loss | Prospective |
Wyss 2012 [61] | Switzerland | Army | Cohort study | Not reported | 18 | Medical attention | Prospective |
Wyss 2014 [60] | Switzerland | Army | Cohort study | Not reported | 18 | Medical attention | Prospective |